Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 Treatments
Paused · Phase 1 · Has a placebo group
Conditions studied: Bipolar Depression, Unipolar Depression
In brief
To demonstrate the efficacy of multiple applications of Low Field Magnetic Stimulation (LFMS) as an antidepressant treatment in subjects with mood disorders.
Key facts
- Study ID
- NCT01557192
- Run by
- Mclean Hospital
- People needed
- 200
- Starts
- 2010-05-01
- Expected to finish
- 2020-05-01
- Last updated by the study team
- 2016-04-13
Who can join
Age: 21 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects MUST be significantly depressed, currently.
- Subjects must not have serious physical illnesses, neurological diseases or dementias.
- Subjects will meet DSM-IV criteria for Bipolar Disorder Type I or II, Major Depressive Disorder, Post Traumatic Stress Disorder, or Obsessive Compulsive Disorder, and be currently depressed.
- Subject must have a Ham-D score > 17, YMRS score < 7 (bipolar subjects only), and a MADRS score > 18.
- Subjects must be capable of providing informed consent.
- Subjects must have an established residence and phone.
- Subjects may be medicated or unmedicated.
You may not qualify if…
- Dangerous or active suicidal ideation.
- Pregnant or planning on becoming pregnant.
- Substance abuse (cannot meet DSM criteria for substance abuse, no significant drug abuse within last 3 months, no major polysubstance abuse history, no history of dependence in last year, no drug use within last month).
- Mixed mood state or rapid cycling.
- Presence of a pacemaker, neurostimulator, or metal in head or neck.
Where it is running
- McLean Hospital — Belmont, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.